The mineralocorticoid receptor agonist, fludrocortisone, inhibits 
pituitary-adrenal activity in humans after pre-treatment with metyrapone

Otte, C.; Jahn, H.; Yassouridis, A.; Arlt, J.; Stober, N.; Maass, P.; Wiedemann, K.; Kellner, M.

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

The mineralocorticoid receptor agonist, fludrocortisone, inhibits pituitary-adrenal activity in humans after pre-treatment with metyrapone

MPS-Authors

/persons/resource/persons80601

Yassouridis, A.
Max Planck Institute of Psychiatry, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Otte, C., Jahn, H., Yassouridis, A., Arlt, J., Stober, N., Maass, P., et al. (2003). The mineralocorticoid receptor agonist, fludrocortisone, inhibits pituitary-adrenal activity in humans after pre-treatment with metyrapone. Life Sciences, 73(14), 1835-1845.

Cite as: https://hdl.handle.net/11858/00-001M-0000-000E-9EA7-E

Abstract

There is no abstract available